News
6d
GlobalData on MSNActio gains $66m to advance small molecule therapeutics pipelineThe financing round was jointly led by new investor Regeneron Ventures and current investor Deerfield Management.
2d
Dealbreaker on MSNDraig Therapeutics Emerges With $140M for Clinical Tests of Novel Neuropsychiatric DrugsThe startup is one of several that have recently raised mega rounds of financing to support programs in the clinic or ...
Trpv4-/- mice resisted TGFβ2-driven increases in IOP. These data establish a fundamental role of TGFβ as a modulator of mechanosensing and identifies TRPV4 channel as a common mechanism for TM ...
Trpv4 −/− mice (N = 6) were injected with LV-TGFβ2 and LV-Ctrl vectors in contralateral eyes . Additionally, two littermate control mice injected alongside the Trpv4 −/− animals were added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results